Abecia, Jean .
HRN: 25-33-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2024
CLINDAMYCIN 300MG (CAP)
06/24/2024
06/30/2024
ORAL
300mg
Q8
IUFD Thickly Msaf
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes